par Body, Jean-Jacques ;Greipp, Philip;Coleman, Robert;Facon, Thierry;Geurs, Filip;Fermand, Jean-Paul;Harousseau, Jean-Luc;Lipton, Allan;Mariette, Xavier;Williams, Catherine;Nakanishi, Arline;Holloway, Donna;Martin, Steven;Dunstan, Colin;Bekker, Pirow
Référence Cancer, 97, 3 Suppl, page (887-892)
Publication Publié, 2003-02
Référence Cancer, 97, 3 Suppl, page (887-892)
Publication Publié, 2003-02
Article révisé par les pairs
Titre: |
|
Auteur: | Body, Jean-Jacques; Greipp, Philip; Coleman, Robert; Facon, Thierry; Geurs, Filip; Fermand, Jean-Paul; Harousseau, Jean-Luc; Lipton, Allan; Mariette, Xavier; Williams, Catherine; Nakanishi, Arline; Holloway, Donna; Martin, Steven; Dunstan, Colin; Bekker, Pirow |
Informations sur la publication: | Cancer, 97, 3 Suppl, page (887-892) |
Statut de publication: | Publié, 2003-02 |
Sujet CREF: | Cancérologie |
MeSH keywords: | Antineoplastic Agents -- administration & dosage -- pharmacokinetics -- therapeutic use |
Bone Neoplasms -- drug therapy -- secondary | |
Bone Resorption -- drug therapy -- metabolism | |
Breast Neoplasms -- pathology | |
Diphosphonates -- administration & dosage -- pharmacokinetics -- therapeutic use | |
Dose-Response Relationship, Drug | |
Double-Blind Method | |
Female | |
Glycoproteins -- administration & dosage -- pharmacokinetics -- therapeutic use | |
Humans | |
Male | |
Middle Aged | |
Multiple Myeloma -- drug therapy | |
Osteoprotegerin | |
Receptors, Cytoplasmic and Nuclear -- administration & dosage -- therapeutic use | |
Receptors, Tumor Necrosis Factor | |
Treatment Outcome | |
Note générale: | Clinical Trial |
Clinical Trial, Phase I | |
Journal Article | |
Randomized Controlled Trial | |
Research Support, Non-U.S. Gov't | |
FLWIN | |
Langue: | Anglais |
Identificateurs: | urn:issn:0008-543X |
info:doi/10.1002/cncr.11138 | |
info:scp/0346837985 | |
info:pmid/12548591 |